Acutaas Chemicals Ltd

Acutaas Chemicals Board Meeting Date

Acutaas Chemicals scheduled a board meeting for July 24, 2026. The board will consider the unaudited financial results for the June 30, 2026 quarter.

Acutaas Chemicals Management Change

Acutaas Chemicals promoted Mr. Anurag Shukla to General Manager Operations & Unit Head. The designation as SMP took effect July 2, 2026.

Acutaas Chemicals Merger & Restructuring Worth ₹5.83 Cr

Acutaas Chemicals Limited's subsidiary ACEPL issued shares to A.R.Z Pharma Ltd for ₹5.83 Crore. Consequently, the parent's stake in ACEPL reduced from 100% to 90%.

Value

₹5.83 Cr

Acutaas Chemicals Merger & Restructuring Worth ₹5.83 Cr

Acutaas Chemicals Ltd subsidiary ACEPL allotted shares worth ₹5.83 Crore to A.R.Z Pharma Ltd. Consequently, ACEPL ceased being wholly-owned, with the parent's stake diluting to 90%.

Value

₹5.83 Cr

Acutaas Chemicals Management Change

Acutaas Chemicals Limited announced the resignation of Senior General Manager Trilok Vasant Sontakke. His departure, effective May 15, 2026, is cited due to personal reasons.

Acutaas Chemicals Earnings Call: Key Takeaways

Acutaas Chemicals delivered record FY26 results with Revenue of ₹13,394 Mn and PAT of ₹3,564 Mn, driven by expansion in pharmaceutical and semiconductor segments.

Acutaas Chemicals Earnings Call: Key Takeaways

Acutaas Chemicals delivered record FY26 performance with ₹1,339.4cr revenue and ₹356.4cr PAT, driven by strong CDMO business and portfolio reshuffling towards high-value pharmaceutical intermediates.

Acutaas Chemicals Other Announcement

Acutaas Chemicals Limited has submitted its Annual Secretarial Compliance Report for the financial year ended March 31, 2026. The report, issued by M/s Kashyap Shah & Co., confirms the company's adherence to SEBI regulations and statutory provisions. No material non-compliances or observations were noted for the review period.

Acutaas Chemicals Earnings Call: Key Takeaways

Acutaas Chemicals delivered strong performance in Q4 FY26, with revenue up 40% and PAT doubling, driven by the high-margin CDMO business and specialty chemicals recovery despite supply chain disruptions.

Acutaas Chemicals Dividend

Acutaas Chemicals Limited has recommended a final dividend of ₹0.5 per equity share for the financial year 2025-26. The dividend is subject to shareholder approval at the upcoming General Meeting. The record date and meeting date will be announced in due course.

Acutaas Chemicals Debt & Borrowing: ₹24.05 Cr

Acutaas Chemicals Limited confirmed it is not classified as a Large Corporate for FY 2026-27 under SEBI norms. The company reported outstanding borrowings of ₹24.05 Crore as of March 31, 2026, and maintains a CARE A1+ credit rating.

Value

₹24.05 Cr

Acutaas Chemicals Dividend

Acutaas Chemicals Limited has recommended a final dividend of Rs. 2.5 per equity share (50%) for FY 2025-26. The dividend is subject to shareholder approval at the upcoming 19th Annual General Meeting. Record and payout dates will be announced later.

Acutaas Chemicals Earnings Call: Key Takeaways

Acutaas Chemicals reported strong Q4FY26 results with 40.3% YoY revenue growth and record PAT margins of 31%. Strategy focuses on Battery Chemicals, Semiconductors, and Pharma CDMO.

Acutaas Chemicals Results Update

Acutaas Chemicals Limited reported strong Q4 FY26 results with revenue of ₹432.8 Crore, up 40.3% YoY. PAT reached ₹134.3 Crore with a record 31% margin. The company is diversifying into high-growth verticals like Battery Chemicals and Semiconductors, and targets 25% revenue growth in FY27.

Value

₹432.8 Cr

Acutaas Chemicals Q4 FY26 Results: Net Profit ₹134.3 Cr, Up 114.2% YoY

Acutaas Chemicals Ltd reported revenue from operations of ₹432.8 Cr (+40.3% YoY) and net profit of ₹134.3 Cr (+114.2% YoY) for Q4 FY26.

Key figure

Net profit ₹134.3 Cr · +114.2% YoY

Acutaas Chemicals Financial Results

Acutaas Chemicals Limited approved its audited standalone and consolidated financial results for the year ended March 31, 2026. The board recommended a final dividend of Rs. 2.50 per share (50%) for FY 2025-26. Additionally, Indichem INC was identified as a material subsidiary of the company.

Acutaas Chemicals Financial Results

Acutaas Chemicals Ltd approved its audited FY26 standalone and consolidated financial results. The board recommended a final dividend of Rs. 2.5 per share (50%) for FY25-26. Additionally, the company re-appointed Cost and Internal Auditors and identified Indichem INC as a material subsidiary.

Acutaas Chemicals Board Meeting Date

Acutaas Chemicals Ltd has scheduled a Board Meeting on April 30, 2026, to approve audited financial results for Q4 and FY26 and consider a final dividend. The trading window for dealing in company shares remains closed until May 2, 2026.

Acutaas Chemicals Other Announcement

Promoters of Acutaas Chemicals Limited confirmed that no shares held by them were pledged or encumbered during the 2025-26 financial year. The declaration, made under SEBI Takeover Regulations, shows the promoter group maintains a 32.66% unencumbered stake in the company as of March 31, 2026.